Corvus Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
CRVS
CUSIP
221015100
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 221015100 since 12/18/2024, largest first.

Filer % of Class Filed
Orbimed Advisors LLC 13D/A
10.3% 1/27/2026
Event 1/23/2026
Miller Richard A MD 13G/A
7.8% 2/13/2026
Event 12/31/2025
Sirenia Capital Management LP 13G
7.5% 5/15/2026
Event 3/31/2026
BlackRock, Inc. 13G/A 7.5% 7/27/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
State Street Corp 13G 4.0% 11/10/2026
Event 9/30/2026
Adams Street Partners, LLC 13D/A
3.9% 2/5/2026
Event 1/23/2026
Point72 Asset Management, L.P. 13G/A
0% 5/15/2026
Event 3/31/2026
Samlyn Capital, LLC 13G/A
0% 8/14/2025
Event 6/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 179 68.8 M $792M
2026 Q2 174 70.7 M $1.06B
2026 Q1 165 70.1 M $1.02B
2025 Q4 126 46.8 M $360M
2025 Q3 105 41.7 M $307M
2025 Q2 96 41.8 M $167M
2025 Q1 93 36.3 M $115M
2024 Q4 91 37.7 M $202M
2024 Q3 66 30.0 M $159M
2024 Q2 48 27.6 M $50.2M
2024 Q1 49 17.9 M $31.9M
2023 Q4 49 19.2 M $33.8M
2023 Q3 53 19.2 M $28.0M
2023 Q2 55 19.5 M $44.6M
2023 Q1 39 20.8 M $18.9M
2022 Q4 43 21.4 M $18.2M
2022 Q3 50 22.1 M $18.1M
2022 Q2 51 25.6 M $25.4M
2022 Q1 60 27.4 M $44.9M
2021 Q4 66 27.7 M $66.7M
2021 Q3 67 28.2 M $136M
2021 Q2 51 23.7 M $63.2M
2021 Q1 50 20.4 M $62.8M
2020 Q4 40 16.3 M $58.1M
2020 Q3 40 17.2 M $69.0M
2020 Q2 39 20.4 M $55.6M
2020 Q1 44 20.7 M $43.6M
2019 Q4 38 20.8 M $113M
2019 Q3 36 22.9 M $68.9M
2019 Q2 46 24.3 M $91.0M
2019 Q1 59 24.8 M $99.5M
2018 Q4 62 25.1 M $92.2M
2018 Q3 62 25.7 M $220M
2018 Q2 57 25.9 M $285M
2018 Q1 55 25.3 M $288M
2017 Q4 54 17.4 M $180M
2017 Q3 54 17.5 M $280M
2017 Q2 52 17.5 M $212M
2017 Q1 52 17.3 M $360M
2016 Q4 53 17.5 M $250M
2016 Q3 45 16.3 M $268M
2016 Q2 45 17.3 M $237M
2016 Q1 32 16.4 M $228M